Dna Group (T.R.) Ltd (TLV:DNA)

Dna Group (T.R.) Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0.31	0.31	0.56	-	-
Revenue Growth (YoY)	-	-45.36%	-	-	-
Gross Profit	0.31	0.31	0.56	-	-
Selling, General & Admin	1.82	2.48	6.26	2.37	1.59
Operating Expenses	1.82	2.48	6.26	2.37	1.59
Operating Income	-1.51	-2.17	-5.7	-2.37	-1.59
Interest Expense	-	-	-	-	-0
Interest & Investment Income	2.79	1.88	0.35	-	-
Earnings From Equity Investments	1.39	0.23	1.24	1.49	-14.66
Currency Exchange Gain (Loss)	0	0.35	0.49	-	-
Other Non Operating Income (Expenses)	-	-	-0.04	7.59	-1.16
EBT Excluding Unusual Items	2.67	0.29	-3.67	6.71	-17.41
Gain (Loss) on Sale of Investments	20.74	-1.47	-19.87	11.67	-1.85
Pretax Income	23.4	-1.18	-23.54	18.37	-19.27
Income Tax Expense	1.31	-	-	-	-
Earnings From Continuing Operations	22.1	-1.18	-23.54	18.37	-19.27
Net Income to Company	22.1	-1.18	-23.54	18.37	-19.27
Net Income	22.1	-1.18	-23.54	18.37	-19.27
Net Income to Common	22.1	-1.18	-23.54	18.37	-19.27
Shares Outstanding (Basic)	123	123	117	87	30
Shares Outstanding (Diluted)	123	123	117	88	30
Shares Change (YoY)	0.03%	5.65%	32.13%	189.68%	21.91%
EPS (Basic)	0.18	-0.01	-0.20	0.21	-0.63
EPS (Diluted)	0.18	-0.01	-0.20	0.21	-0.63
Free Cash Flow	1.61	-0.68	-0.35	-2.33	-0.61
Free Cash Flow Per Share	0.01	-0.01	-0.00	-0.03	-0.02
Gross Margin	100.00%	100.00%	100.00%	-	-
Operating Margin	-493.46%	-710.46%	-1017.68%	-	-
Profit Margin	7220.91%	-384.64%	-4202.86%	-	-
Free Cash Flow Margin	526.14%	-221.57%	-63.21%	-	-
EBIT	-1.51	-2.17	-5.7	-2.37	-1.59
Effective Tax Rate	5.58%	-	-	-	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.